All Learning Centers

Infectious disease and vaccination center

Measles: More Than a Rash

One evidence packet. Four biomedical lenses. Decide what the data support, explain what measles changes inside immune memory, choose a proportionate intervention, and repair a chart that says more than its sources can prove.

Case file MMR-2025

Your county needs one message it can defend

You are on a biomedical evidence team preparing a school-community briefing. A supplied chart appears to connect falling vaccination coverage with rising measles cases. Your job is to check the numbers, explain the biology, choose a proportionate intervention, and rebuild the display so it says only what the evidence supports.

Time
35-50 minutes
Product
One evidence defense
Outside research
Not required

Evidence packet

2025 U.S. surveillance snapshot

CDC reports 2,288 confirmed U.S. measles cases for 2025. Twelve percent were hospitalized, and three confirmed deaths were reported.

Evidence limit: CDC still marks the 2025 count as preliminary and subject to change. This is a national total, not a local risk estimate.

CDC: Measles Cases and Outbreaks

Kindergarten MMR coverage

National kindergarten MMR coverage decreased from 95.2% in 2019-2020 to 92.5% in 2024-2025.

Evidence limit: These values describe U.S. kindergarteners by school year. They do not describe every age group or every community.

CDC SchoolVaxView

MMR effectiveness

CDC reports that one MMR dose is 93% effective and two doses are 97% effective at preventing measles.

Evidence limit: Effectiveness is a population estimate. It does not promise that every vaccinated person is protected in every exposure.

CDC: Measles Cases and Outbreaks

Complications and delayed harm

CDC estimates about one encephalitis case and two to three deaths per 1,000 reported cases. SSPE was estimated at 7 to 11 cases per 100,000 measles cases in the 1989-1991 U.S. resurgence.

Evidence limit: These are historical population estimates. They do not predict the outcome for one person.

CDC Surveillance Manual, Chapter 7

One immune amnesia study

In one study, Mina and colleagues followed 77 unvaccinated children before and two months after natural measles infection. Across individuals, 11% to 73% of the measured preexisting antibody repertoire was lost. The MMR-vaccinated comparison group did not show the same loss.

Evidence limit: The range varied across individuals. The study supports loss of humoral immune memory, but it does not establish the duration of every child's increased susceptibility.

Mina et al., Science (2019), PMID 31672891

Audit of the supplied trend figure

The supplied figure labels 2025 as 2,289 cases. Current CDC reporting gives 2,288. Its vaccination line does not identify the measured population or a source.

Evidence limit: A dual-axis figure with mismatched populations and time bases can suggest a causal relationship the data do not prove.

Comparison of the supplied figure with current CDC reporting

Separate the measurements before comparing them

Selected annual U.S. measles case counts

Confirmed cases reported to CDC. The 2025 value remains preliminary.

Source: CDC Measles Cases and Outbreaks. The selected years support comparison, not a complete time-series model.

U.S. kindergarten MMR coverage

These percentages describe kindergarteners by school year.

2019-202095.2%
2024-202592.5%

Read the values, not just the bar length. The scale begins at 0%, so the display does not magnify a 2.7 percentage-point change.

Source: CDC SchoolVaxView. Do not treat this age-specific national average as every community's coverage.

What the pair supports

The displays show a recent decrease in national kindergarten MMR coverage and a high 2025 national case count. They do not prove that the first caused the second. Local coverage, imported infections, contact patterns, outbreak clustering, and surveillance all matter.

Choose your course lens

PBS challenge

Outbreak evidence audit

Observation, pattern, and justified claims

Decide which claim is strongest: (A) measles cases rose while kindergarten coverage fell, (B) the national coverage change caused the 2025 outbreaks, or (C) MMR stopped working. Defend your choice with E1, E2, E3, and E6.

Use this frame

The evidence supports ___ because E__ shows ___. It does not prove ___ because ___.

Required evidence: E1, E2, E3, E6

Connected lessons
  • Chain of infection
  • Outbreak evidence
Check your reasoning

Claim A is supported as a time pattern. Claims B and C exceed the evidence. The two national series use different populations and time bases, and E3 still reports high vaccine effectiveness.

Course claim ceiling: Describe an association or pattern. Do not claim that the national coverage change caused a specific outbreak.

Exit ticket: one claim worth defending

Write a three-part response using at least two evidence IDs.

  1. 1. CLAIM

    State one conclusion that fits the evidence.

  2. 2. EVIDENCE

    Cite two evidence IDs and name the relevant values or findings.

  3. 3. LIMIT

    Name one conclusion the packet cannot support.

Evidence checked August 11, 2026. CDC continues to mark 2025 surveillance counts as preliminary. Go Hornets.